Keywords: Meningitis; SOMAmer; AlN gravimetric biosensor; PavA; FHbp;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: OMV; Outer Membrane Vesicles; Surface display; Heterologous expression; Lipoprotein; Borrelia burgdorferi; Neisseria meningitidis; OspA; fHbp;
Keywords: anti-B PS IgM Ab; anti-serogroup B capsular polysaccharide IgM antibodies; BCA; bactericidal activity test; CFU; colony forming unit; ELISA; enzyme-linked immunosorbent assay; fH; factor H; fHbp; factor H-binding protein; GMT; geometric mean titre; IMD; i
Keywords: Neisseria meningitidis; Meningococcal disease; MenB vaccine; Vaccine evaluation; GNA; genome-derived Neisserial antigen; fHbp; factor H-binding protein; NadA; Neisserial adhesin A; NHBA; Neisserial heparin-binding antigen; cc; clonal complex; MenA; serogr
Individual variability in humoral response of immunized outbred mice and cross-reactivity with prevalent Brazilian Neisseria meningitidis strains
Keywords: AI; avidity index; CSF; cerebrospinal fluid; ELISA; enzyme-linked immunosorbent assay; FbpA; ferric binding protein A; FetA; ferric enterobactin A; fHbp; factor H binding protein; HLA; human leucocyte antigen; LPS; lipopolyssacharide; MenB; Neisseria meni
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults
Keywords: ACIP; Advisory Committee on Immunization Practices; EMA; European Medicines Agency; FDA; US Food and Drug Administration; FHbp; factor H binding protein; GMT; geometric mean titer; HPV; human papillomavirus; hSBA; serum bactericidal assay using human comp
Bivalent rLP2086 (Trumenba®): Development of a well-characterized vaccine through commercialization
Keywords: DOE; design of experiments; DS; drug substance; ELISA; enzyme-linked immunosorbent assay; FDA; US Food and Drug Administration; FHbp; factor H binding protein; HCP; host cell proteins; NmB; Neisseria meningitidis serogroup B; Nm; Neisseria meningitidis; R
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C
Keywords: Neisseria meningitidis; Vaccine; Neisserial Heparin binding antigen; Factor H binding protein; FHbp; Complement;
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Keywords: 4CMenB vaccination; Reduced doses; Catch-up dose; Infants; Children; AE; adverse event; CI; confidence interval; 4CMenB; multi-component vaccine against MenB; fHbp; factor H binding protein; GMT; geometric mean titers; hSBA; serum bactericidal assay with
Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers
Keywords: Neisseria meningitidis; Serogroup B; Vaccine; Meningococcal disease; Bivalent rLP2086; Laboratory worker; ACIP; Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; fHBP; factor H binding protein; GMT; geometric mean t
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Keywords: AE; adverse event; fHBP; factor H binding protein; HAV; hepatitis A virus vaccine; IMD; invasive meningococcal disease; MAE; medically-attended adverse event; MnB; Neisseria meningitidis serogroup B; NDCMC; newly-diagnosed chronic medical condition; SAE;
A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice
Keywords: Vaccine; Factor H binding protein; FHbp; OMV; PorA; Colonization model; Neisseria meningitidis; NOMV; native outer membrane vesicle; dOMV; detergent-treated OMV; CEACAM; carcinoembryonic antigen-related cell adhesion molecule;
Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
Keywords: MenB; serogroup B meningococcal; fHbp; factor H binding protein; NadA; Neisseria adhesin A; NHBA; Neisseria heparin binding antigen; PorA; porin A; hSBA; serum bactericidal assay using human complement; GMC; geometric mean concentration; GMT; geometric me
Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis
Keywords: Hajj clone; Invasive meningococcal disease; W135; Whole genome sequencing; Virulence factors; FHbp
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults
Keywords: IMD; invasive meningococcal disease; MenC; serogroup C meningococcal disease; MenB; serogroup B meningococcal disease; MCCV; meningococcal serogroup C conjugate vaccine; MenACWY; serogroups A, C, W, Y meningococcal disease; OMV; outer membrane vesicle; fH
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
Keywords: NCT01272180; Conjugate vaccines; Meningococcal; Immunogenicity; Safety; Adolescent; hSBA; serum bactericidal activity with human complement; fHbp; factor H-binding protein; NadA; Neisseria adhesin A; NHBA; Neisserial Heparin Binding Antigen; OMV; outer me
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
Keywords: CC; clonal complex; ELISA; enzyme-linked immunosorbent assay; fHBP; factor H binding protein; FN; false negatives; FP; false positives; HPA; Health Protection Agency; hSBA; serum bactericidal antibody assay with human complement; IMD; invasive meningococc
Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice
Keywords: fHbp; Animal model; Bactericidal; Mutant fHbp vaccine; fH; Variant group 2; Sub-family A;
fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations
Keywords: fH; factor H; fHbp; factor H-binding protein; NspA; Neisseria surface protein A; Neisseria meningitidis; Vaccine; Complement; Factor H; fHbp; NspA; Transgenic rat;
Distribution of factor H binding protein beyond serogroup B: Variation among five serogroups of invasive Neisseria meningitidis in South Africa
Keywords: Neisseria meningitidis; South Africa; Serosubtype; Clonal complex; fHBP; Serogroup B;
Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys
Keywords: Neisseria meningitidis; fHbp; OMV; Adjuvants;
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1
Keywords: Neisseria meningitidis; fHbp; Isogenic strains; Serum bactericidal activity; Vaccine;
Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates
Keywords: Meningococcal vaccine; FHbp; Genetic lineage; Recombination
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
Keywords: N. meningitidis serogroup B; Vaccine; LP2086; fHBP
Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
Keywords: Meningococcal vaccine antigens; Reverse vaccinology; fHBP; NadA; GNA2132; GNA2091; GNA1030
A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups
Keywords: Neisseria meningitidis; fHbp; mAb epitope; Peptide phage display; Vaccine; Bactericidal
Microbial complement inhibitors as vaccines
Keywords: CRP; C-reactive protein; MAC; membrane-attack complex; C4bp; C4b binding protein; GAS; group A streptococcusS. pyogenes; fHbp; factor H binding protein; Complement; Factor H; C4bp; Meningococcus; Borrelia; Yersinia;